Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis

To study the safety profile and characterize the immunologic effects of high- vs low-dose cholecalciferol supplementation in patients with multiple sclerosis (MS). In this double-blind, single-center randomized pilot study, 40 patients with relapsing-remitting MS were randomized to receive 10,400 IU...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology Jg. 86; H. 4; S. 382
Hauptverfasser:	Sotirchos, Elias S, Bhargava, Pavan, Eckstein, Christopher, Van Haren, Keith, Baynes, Moira, Ntranos, Achilles, Gocke, Anne, Steinman, Lawrence, Mowry, Ellen M, Calabresi, Peter A
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 26.01.2016
Schlagworte:	Adult CD4 Lymphocyte Count CD4-Positive T-Lymphocytes - metabolism Cholecalciferol - administration & dosage Cholecalciferol - adverse effects Cholecalciferol - pharmacology Dietary Supplements Double-Blind Method Female Humans Immunologic Factors - administration & dosage Immunologic Factors - adverse effects Immunologic Factors - pharmacology Interleukin-17 - metabolism Male Middle Aged Multiple Sclerosis, Relapsing-Remitting - drug therapy Multiple Sclerosis, Relapsing-Remitting - immunology Pilot Projects Treatment Outcome Vitamin D - analogs & derivatives Vitamin D - blood
ISSN:	1526-632X, 1526-632X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!